晚期胃癌-话题@MedSci

#晚期胃癌#

96篇内容 | 4247人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276643, encodeId=b3c212e664381, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响, objectType=article, longId=221553, objectId=243b2215533b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243b2215533b, replyNumber=0, likeNumber=76, createdTime=2021-12-06, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243b2215533b, moduleTitle=Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243b2215533b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276642, encodeId=9bfb12e66422d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Oncologist: Apatinib（阿帕替尼）与S-1联合一线治疗晚期胃癌疗效和安全性, objectType=article, longId=221378, objectId=de1e2213e8db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de1e2213e8db, replyNumber=0, likeNumber=99, createdTime=2021-12-02, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de1e2213e8db, moduleTitle=Oncologist: Apatinib（阿帕替尼）与S-1联合一线治疗晚期胃癌疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de1e2213e8db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276641, encodeId=b45412e664137, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究, objectType=article, longId=221208, objectId=1c1e22120872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1e22120872, replyNumber=0, likeNumber=91, createdTime=2021-11-30, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1e22120872, moduleTitle=Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1e22120872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276640, encodeId=0e7a12e6640de, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究, objectType=article, longId=221042, objectId=3d7022104236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d7022104236, replyNumber=0, likeNumber=97, createdTime=2021-11-27, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d7022104236, moduleTitle=晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d7022104236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276639, encodeId=0dcb12e663961, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=脾多肽联合阿帕替尼治疗晚期胃癌的临床研究, objectType=article, longId=221025, objectId=d3a3221025cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a3221025cb, replyNumber=0, likeNumber=70, createdTime=2021-11-27, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a3221025cb, moduleTitle=脾多肽联合阿帕替尼治疗晚期胃癌的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a3221025cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276638, encodeId=0d4a12e66384d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=晚期胃癌化疗的历史和现状, objectType=article, longId=220902, objectId=e66f22090204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66f22090204, replyNumber=0, likeNumber=64, createdTime=2021-11-25, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66f22090204, moduleTitle=晚期胃癌化疗的历史和现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66f22090204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276637, encodeId=311912e6637d3, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=替吉奥胶囊联合顺铂治疗晚期胃癌的临床疗效, objectType=article, longId=220679, objectId=05a82206e9ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05a82206e9ee, replyNumber=0, likeNumber=85, createdTime=2021-11-22, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05a82206e9ee, moduleTitle=替吉奥胶囊联合顺铂治疗晚期胃癌的临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05a82206e9ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276636, encodeId=624e12e6636da, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=经股动脉皮下埋植化疗泵持续动脉化疗与静脉化疗治疗晚期胃癌的临床效果和安全性比较, objectType=article, longId=220673, objectId=a55c2206e331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a55c2206e331, replyNumber=0, likeNumber=76, createdTime=2021-11-22, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a55c2206e331, moduleTitle=经股动脉皮下埋植化疗泵持续动脉化疗与静脉化疗治疗晚期胃癌的临床效果和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a55c2206e331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276635, encodeId=96c612e6635e8, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究, objectType=article, longId=219112, objectId=3ad22191126f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ad22191126f, replyNumber=0, likeNumber=100, createdTime=2021-10-25, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ad22191126f, moduleTitle=Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ad22191126f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276634, encodeId=895512e6634d9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！, objectType=article, longId=218209, objectId=f08c2182095b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08c2182095b, replyNumber=0, likeNumber=86, createdTime=2021-10-09, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08c2182095b, moduleTitle=Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08c2182095b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276633, encodeId=8f7f12e663341, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, objectType=article, longId=218067, objectId=2f5021806e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f5021806e4d, replyNumber=0, likeNumber=84, createdTime=2021-10-04, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f5021806e4d, moduleTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f5021806e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276632, encodeId=a00912e663207, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=突破十年瓶颈，欧狄沃®联合化疗方案获批成为中国且唯一晚期胃癌一线免疫疗法, objectType=article, longId=215640, objectId=f3ab215640e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ab215640e1, replyNumber=0, likeNumber=93, createdTime=2021-08-14, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ab215640e1, moduleTitle=突破十年瓶颈，欧狄沃®联合化疗方案获批成为中国且唯一晚期胃癌一线免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ab215640e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276631, encodeId=f00912e663147, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后, objectType=article, longId=213692, objectId=780621369207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780621369207, replyNumber=0, likeNumber=71, createdTime=2021-07-05, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780621369207, moduleTitle=Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780621369207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276630, encodeId=180b12e6630e9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：晚期胃癌中二线化疗中早期肿瘤应答和生活质量的关系：ABSOLUTE研究的更新, objectType=article, longId=213485, objectId=2ce5213485af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ce5213485af, replyNumber=0, likeNumber=74, createdTime=2021-07-01, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ce5213485af, moduleTitle=Gastric Cancer：晚期胃癌中二线化疗中早期肿瘤应答和生活质量的关系：ABSOLUTE研究的更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ce5213485af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276629, encodeId=d91a12e6629d9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新, objectType=article, longId=213460, objectId=af9621346022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9621346022, replyNumber=0, likeNumber=80, createdTime=2021-06-30, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9621346022, moduleTitle=Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9621346022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276628, encodeId=4c5312e6628bf, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, objectType=article, longId=212904, objectId=f025212904a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f025212904a5, replyNumber=0, likeNumber=85, createdTime=2021-06-20, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f025212904a5, moduleTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f025212904a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276627, encodeId=3c0012e66274d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究, objectType=article, longId=212152, objectId=b749212152b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b749212152b2, replyNumber=0, likeNumber=87, createdTime=2021-06-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b749212152b2, moduleTitle=Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b749212152b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276626, encodeId=f19212e662691, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法, objectType=article, longId=210099, objectId=8c11210099b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c11210099b0, replyNumber=0, likeNumber=52, createdTime=2021-04-19, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c11210099b0, moduleTitle=O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c11210099b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276625, encodeId=964112e6625c3, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性, objectType=article, longId=206331, objectId=9adb20633151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9adb20633151, replyNumber=0, likeNumber=63, createdTime=2021-01-29, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adb20633151, moduleTitle=Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9adb20633151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276624, encodeId=17ce12e6624b8, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！, objectType=article, longId=205187, objectId=74bc20518eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74bc20518eef, replyNumber=0, likeNumber=91, createdTime=2021-01-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74bc20518eef, moduleTitle=Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74bc20518eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胃癌

2020-05-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Front Oncol：TMB状态对抗HER2治疗在HER2阳性晚期胃癌(AGC)的疗效的影响

2021-12-06

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Oncologist: Apatinib（阿帕替尼）与S-1联合一线治疗晚期胃癌疗效和安全性

2021-12-02

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究

2021-11-30

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究

2021-11-27

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

脾多肽联合阿帕替尼治疗晚期胃癌的临床研究

2021-11-27

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

晚期胃癌化疗的历史和现状

2021-11-25

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

替吉奥胶囊联合顺铂治疗晚期胃癌的临床疗效

2021-11-22

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

经股动脉皮下埋植化疗泵持续动脉化疗与静脉化疗治疗晚期胃癌的临床效果和安全性比较

2021-11-22

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究

2021-10-25

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！

2021-10-09

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性

2021-10-04

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

突破十年瓶颈，欧狄沃®联合化疗方案获批成为中国且唯一晚期胃癌一线免疫疗法

2021-08-14

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后

2021-07-05

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：晚期胃癌中二线化疗中早期肿瘤应答和生活质量的关系：ABSOLUTE研究的更新

2021-07-01

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新

2021-06-30

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后

2021-06-20

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究

2021-06-03

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法

2021-04-19

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性

2021-01-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！

2021-01-03

科室
- - 订阅+
  - 更多科室
工具
服务